138 related articles for article (PubMed ID: 3486843)
1. Immunoprofile of reactions in leprosy.
Sehgal VN; Gautam RK; Sharma VK
Int J Dermatol; 1986 May; 25(4):240-4. PubMed ID: 3486843
[TBL] [Abstract][Full Text] [Related]
2. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
3. Serum immunoglobulin profile and C3 level in lepromatous leprosy patients.
Harikrishan S; Balakrishnan S; Bhatia VN
Lepr India; 1982 Jul; 54(3):454-60. PubMed ID: 7176534
[TBL] [Abstract][Full Text] [Related]
4. Erythema nodosum leprosum (ENL) in histoid leprosy.
Sehgal VN; Gautam RK; Srivastava G; Koranne RV; Beohar PC
Indian J Lepr; 1985; 57(2):346-9. PubMed ID: 4078360
[TBL] [Abstract][Full Text] [Related]
5. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1986; 58(4):601-8. PubMed ID: 2952738
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL).
Sharma VK; Saha K; Sehgal VN
Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448
[TBL] [Abstract][Full Text] [Related]
7. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
[TBL] [Abstract][Full Text] [Related]
8. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
9. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.
Negera E; Walker SL; Bekele Y; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006121. PubMed ID: 29253897
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy.
Shannon EJ; Miranda RO; Morales MJ; Hastings RC
Scand J Immunol; 1981; 13(6):553-62. PubMed ID: 7031850
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
[TBL] [Abstract][Full Text] [Related]
12. Immunological status of maculo-anaesthetic leprosy: T and B lymphocytes and serum immunoglobulins.
Rao SS; Rao TD; Rao PR
Lepr India; 1982 Jul; 54(3):471-8. PubMed ID: 6983629
[TBL] [Abstract][Full Text] [Related]
13. An appraisal of third complement component (C3) and breakdown product (C3d) in erythema nodosum leprosum (ENL).
Saha K; Chakraborty AK; Sharma V; Sehgal VN
Lepr Rev; 1982 Dec; 53(4):253-60. PubMed ID: 6984124
[No Abstract] [Full Text] [Related]
14. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
15. The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction.
Sehgal VN; Sharma V; Sharma VK
Br J Dermatol; 1988 Aug; 119(2):255-8. PubMed ID: 3166944
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive evaluation of complement components in the course of type I (Lepra) and type II (ENL) reactions.
Sehgal VN; Sharma V; Sharma VK
Int J Dermatol; 1989; 28(1):32-5. PubMed ID: 2783924
[TBL] [Abstract][Full Text] [Related]
17. Lucio's phenomenon: an immune complex deposition syndrome in lepromatous leprosy.
Quismorio FP; Rea T; Chandor S; Levan N; Friou GJ
Clin Immunol Immunopathol; 1978 Feb; 9(2):184-93. PubMed ID: 618690
[No Abstract] [Full Text] [Related]
18. Biochemical, immunological and genetic studies in leprosy. II. Profile of immunoglobulins, complement components and C-reactive protein in sera of leprosy patients and healthy controls.
Srivastava LM; Agarwal DP; Goedde HW; Rohde R
Tropenmed Parasitol; 1975 Jun; 26(2):212-8. PubMed ID: 1162738
[TBL] [Abstract][Full Text] [Related]
19. T-cell regulation in Erythema Nodosum Leprosum.
Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
[TBL] [Abstract][Full Text] [Related]
20. Immunological assessment of sera of leprosy patients.
Sengupta U; Sinha S; Ramu G
Lepr India; 1979 Jan; 51(1):43-8. PubMed ID: 449283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
